The first experience of using the "Senhance" robotic surgical system during cholecystectomy

The aim of our study was to evaluate the differences in intra­operative and postoperative outcomes of cholecystectomy using the Senhance robotic platform and laparoscopic cholecystectomy. A retrospective analysis of medical cases history of patients who underwent cholecystectomy from December 2021 t...

Full description

Saved in:
Bibliographic Details
Main Authors: M.A. Kashtalian, Ie.A. Kvasnevskyi, O.A. Kvasnevskyi
Format: Article
Language:English
Published: Dnipro State Medical University 2023-09-01
Series:Medičnì Perspektivi
Subjects:
Online Access:https://journals.uran.ua/index.php/2307-0404/article/view/289167
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841564412244131840
author M.A. Kashtalian
Ie.A. Kvasnevskyi
O.A. Kvasnevskyi
author_facet M.A. Kashtalian
Ie.A. Kvasnevskyi
O.A. Kvasnevskyi
author_sort M.A. Kashtalian
collection DOAJ
description The aim of our study was to evaluate the differences in intra­operative and postoperative outcomes of cholecystectomy using the Senhance robotic platform and laparoscopic cholecystectomy. A retrospective analysis of medical cases history of patients who underwent cholecystectomy from December 2021 to February 2022 was conducted. The treatment outcomes of patients with chronic calculous cholecystitis who underwent robotic cholecystectomy (RC) were compared with those who underwent laparoscopic cholecystectomy (LC). Robotic cholecystectomy was performed using the Senhance robotic platform. The RC and LC groups were matched for age, sex, body mass index and compared for the duration of the operation and hospital stay. For normally distributed data, the mean and standard deviation, determined using the Shapiro-Wilk test (p-value>0.05), were applied. Median and interquartile range (IQR) were also used. Difference between cohorts - 95% confidence interval (95% Confidence Interval) were estimated for normally distributed data. Data analysis was performed using standard summary statistics on the Jamovi 2.2.5 platform. Data were processed using application program packages. All surgical procedures were performed by two surgeons from Odesa National Medical University. Robotic cholecystectomy was performed on 18 pa­tients and laparoscopic cholecystectomy was performed on 20 patients. There were no statistically significant differences between the groups in terms of length of hospital stay, blood loss or complications. There were no bile duct injuries, intra­operative complications, or conversions in either group. The only statistically significant difference was the total time under anesthesia (p>0.05), which was longer in the robotic cholecystectomy group. Cholecystectomy using the Senhance robotic platform was found to be safe, with an average operative time of 35.2±5.0 minutes, while the duration of laparoscopic cholecystectomy was 32.2±3.3 minutes. The study results showed that robotic cholecystectomy using the Senhance system is safe and effective. The use of robotic systems can improve precision and control during surgery, reduce blood loss and complications.
format Article
id doaj-art-a79ede327d1f49d9bcfd5aa66c59292f
institution Kabale University
issn 2307-0404
language English
publishDate 2023-09-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-a79ede327d1f49d9bcfd5aa66c59292f2025-01-02T22:45:40ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042023-09-01283798510.26641/2307-0404.2023.3.289167327439The first experience of using the "Senhance" robotic surgical system during cholecystectomyM.A. Kashtalian0https://orcid.org/0000-0002-2945-2161Ie.A. Kvasnevskyi1https://orcid.org/0000-0002-0753-7666O.A. Kvasnevskyi2https://orcid.org/0000-0001-6630-0143Odesa national medical university, Valikhovskyi lane, 2, Odesa, 65082Odesa national medical university, Valikhovskyi lane, 2, Odesa, 65082Odesa national medical universityThe aim of our study was to evaluate the differences in intra­operative and postoperative outcomes of cholecystectomy using the Senhance robotic platform and laparoscopic cholecystectomy. A retrospective analysis of medical cases history of patients who underwent cholecystectomy from December 2021 to February 2022 was conducted. The treatment outcomes of patients with chronic calculous cholecystitis who underwent robotic cholecystectomy (RC) were compared with those who underwent laparoscopic cholecystectomy (LC). Robotic cholecystectomy was performed using the Senhance robotic platform. The RC and LC groups were matched for age, sex, body mass index and compared for the duration of the operation and hospital stay. For normally distributed data, the mean and standard deviation, determined using the Shapiro-Wilk test (p-value>0.05), were applied. Median and interquartile range (IQR) were also used. Difference between cohorts - 95% confidence interval (95% Confidence Interval) were estimated for normally distributed data. Data analysis was performed using standard summary statistics on the Jamovi 2.2.5 platform. Data were processed using application program packages. All surgical procedures were performed by two surgeons from Odesa National Medical University. Robotic cholecystectomy was performed on 18 pa­tients and laparoscopic cholecystectomy was performed on 20 patients. There were no statistically significant differences between the groups in terms of length of hospital stay, blood loss or complications. There were no bile duct injuries, intra­operative complications, or conversions in either group. The only statistically significant difference was the total time under anesthesia (p>0.05), which was longer in the robotic cholecystectomy group. Cholecystectomy using the Senhance robotic platform was found to be safe, with an average operative time of 35.2±5.0 minutes, while the duration of laparoscopic cholecystectomy was 32.2±3.3 minutes. The study results showed that robotic cholecystectomy using the Senhance system is safe and effective. The use of robotic systems can improve precision and control during surgery, reduce blood loss and complications.https://journals.uran.ua/index.php/2307-0404/article/view/289167senhance surgical systemcholecystectomyminimally invasive surgeryrobotic surgery
spellingShingle M.A. Kashtalian
Ie.A. Kvasnevskyi
O.A. Kvasnevskyi
The first experience of using the "Senhance" robotic surgical system during cholecystectomy
Medičnì Perspektivi
senhance surgical system
cholecystectomy
minimally invasive surgery
robotic surgery
title The first experience of using the "Senhance" robotic surgical system during cholecystectomy
title_full The first experience of using the "Senhance" robotic surgical system during cholecystectomy
title_fullStr The first experience of using the "Senhance" robotic surgical system during cholecystectomy
title_full_unstemmed The first experience of using the "Senhance" robotic surgical system during cholecystectomy
title_short The first experience of using the "Senhance" robotic surgical system during cholecystectomy
title_sort first experience of using the senhance robotic surgical system during cholecystectomy
topic senhance surgical system
cholecystectomy
minimally invasive surgery
robotic surgery
url https://journals.uran.ua/index.php/2307-0404/article/view/289167
work_keys_str_mv AT makashtalian thefirstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy
AT ieakvasnevskyi thefirstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy
AT oakvasnevskyi thefirstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy
AT makashtalian firstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy
AT ieakvasnevskyi firstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy
AT oakvasnevskyi firstexperienceofusingthesenhanceroboticsurgicalsystemduringcholecystectomy